Clinical Trial Update: Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study of inotuzumab ozogamicin in combination chemotherapy for acute lymphoblastic leukemia, including Philadel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Lymphoblastic Leukemia Philadelphia Chromosome-negative

Drugs mentioned

• Besponsa (inotuzumab ozogamicin)
• Combination chemotherapy

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | Phase 1, Phase 2 | Status: RECRUITING